Comments
Loading...

Health In Tech Analyst Ratings

HITNASDAQ
Logo brought to you by Benzinga Data

Health In Tech Analyst Ratings and Price Targets | NASDAQ:HIT | Benzinga

Health In Tech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Health In Tech Corp from these most-recent analyst ratings.

Analyst Ratings for Health In Tech

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Health In Tech (HIT) stock?

A

There is no price target for Health In Tech

Q

What is the most recent analyst rating for Health In Tech (HIT)?

A

There is no analyst for Health In Tech

Q

When was the last upgrade for Health In Tech (HIT)?

A

There is no last upgrade for Health In Tech

Q

When was the last downgrade for Health In Tech (HIT)?

A

There is no last downgrade for Health In Tech.

Q

When is the next analyst rating going to be posted or updated for Health In Tech (HIT)?

A

There is no next analyst rating for Health In Tech.

Q

Is the Analyst Rating Health In Tech (HIT) correct?

A

There is no next analyst rating for Health In Tech.

Browse analyst ratings and price targets on all stocks.

People Also Watch